IP
IndiaPulse

Max Financial Services Limited (MFSL)

Mid Cap

Financial Services stocks · Mid cap · NSE

Max Financial Services Limited (MFSL) is a holding company whose primary operating asset is Axis Max Life Insurance. It provides life insurance products across various categories including protection, savings, annuity, and ULIPs, distributed through proprietary and partnership channels.

₹1,548.4
+11.40 · +0.74%
Quote04 Sept, 03:56 pm IST
Fundamentals05 Sept 2026 · screener
Score05 Sept, 10:20 pm IST · v4.3-runtime-valuation
Tags03 May 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Financial Services P/E 18.5 (n=240)
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Weak fundamentals, management trust needs verification, price trend argues for patience, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
OVERVALUED
10

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Mixed Trust
55

medium confidence · 3/6 claims checked

Technical
Bearish
32

Timing lens: price trend and sector relative strength.

Result consistency
weak
35

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 30 Jun 2026

Good · 67/100

Rev +17% YoY · PAT +37% YoY · +39% QoQ · operating leverage · margin compression

Filed 13 Aug 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹14,970 Cr+16.8%+38.6%
EBITDA₹167 Cr+40.3%+2883.3%
Operating margin1.1%+20 bps+120 bps
PAT₹118 Cr+37.2%NDF
PAT margin0.8%+12 bps+109 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business & thesis

Growth engines, tailwinds/headwinds, and risk radar from management commentary

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-06-14T08:53:55.432Z
Management commentary snapshot

MFSL's consolidated revenue (ex-investment income) grew 17% YoY in FY26, with Axis Max Life Insurance reporting strong VNB growth of 26% and NBM expansion to 25.2%. Individual Adjusted First Year Premium rose 19%, outpacing private industry growth.

Axis Max Life Insurance demonstrated robust performance in FY26, with strong VNB growth, NBM expansion, and market share gains. Proprietary channels and specific product segments like Annuity and Retail Protection showed significant momentum, supporting the overall growth trajectory.

Current business mix

Axis Max Life APE Channel Mix

Latest issuer-disclosed distribution across 2 reported categories.

Businessmix
Proprietary45.0%
Partnership55.0%
Growth engines

Proprietary Channels

Proprietary channels APE grew by 28% on YoY basis driven by secular growth momentum within Offline and Online proprietary channels.

Annuity APE

Annuity APE grew by 113% to Rs 1,050 cr during FY’26 vs Rs 492 cr during FY’25.

Retail Protection and Health APE

Retail Protection and Health APE grew by 53% to Rs 1,373 cr during FY’26 vs Rs 896 cr last year.

New Partnerships

New partnership APE grew by 90% YoY during FY’26, contributing >5% of Individual APE.

Tailwinds

Balanced Product Mix

VNB growth and NBM expansion driven by a balanced product mix and higher business volumes.

Focus on Longer Term Products

Focus is on selling longer term products along with improving penetration of pure protection & Health offerings.

Customer Measures

Focus towards customer measures has helped deliver performance across health parameters and will continue to remain a priority.

Headwinds

Non-Operating Variance

Non-operating variance is Rs -714 cr in FY26.

Solvency Ratio Decline

Solvency ratio at 194% as of Mar’26, down from 201% in FY25.

Policyholder Expense to GWP Ratio Increase

Policyholder Expense to GWP Ratio increased to 14.6% in FY26 from 13.6% in FY25.

Risk radar

Mortality Risk

10% increase in mortality leads to a 3.1% decrease in EV and 7.2% decrease in VNB.

Expense Risk

10% increase in expenses leads to a 0.9% decrease in EV and 9.1% decrease in VNB.

Corporate Tax Rate Increase

2% increase in corporate tax rate leads to a 2.4% decrease in EV and 3.5% decrease in VNB. Increase to 25% leads to 10.5% EV fall.

Management accountability

What management said, and what results must prove

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare YOY

The investor release provides annual financial performance for FY26, with comparisons explicitly stated on a Year-on-Year basis against FY25, making YoY the most relevant comparison for assessing long-term trends and growth.

Sector KPIs management disclosed

MFSL Consolidated Revenue (ex-investment income)

MFSL revenue* excluding investment income at Rs 38,039 cr, grows 17% in FY’26.

Axis Max Life Individual Adjusted First Year Premium

Individual Adjusted first year Premium is at Rs 9,885 cr grew by 19% on YoY basis, ahead of the private industry which grew by 12% YoY.

Axis Max Life Private Market Share

Private Market share at 10.4% during FY’26 expanded by 56 bps from 9.8% during FY’25.

Axis Max Life Value of New Business (VNB)

FY’26 VNB at Rs 2,647 cr grew by 26% YoY.

Management forward view

Strategic Focus

Axis Max Life has focused on ensuring growth in both its Proprietary and Bancassurance channels.

Product Innovation

Launched Online Savings Plan Plus, Corporate Advantage in Retirement and Employee Benefit Smart Plan, and Group Smart Health Insurance Plan.

Protection and Retirement Focus

Protection and Retirement remains a key focus area for Axis Max life due to the long-term structural opportunity within the segment.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
New Business Margin (NBM)25.2% in FY26Sustained expansion or stability, indicating profitable growth and effective product mix management.
Proprietary Channels APE Growth28% YoY in FY26Continued outperformance relative to partnership channels, supporting margin bias.
Solvency Ratio194% as of Mar’26Maintenance above regulatory requirements and stability, indicating capital adequacy.
Policyholder Expense to GWP Ratio14.6% in FY26Trends in operational efficiency, as the ratio increased YoY.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Show extracted source claims
revenue outlooknot yet verifiablequantified

Max Life aims for 3-4 times sales growth in protection and health.

Timeframe: 5 years (by FY26)Direction: increaseConfidence: aspiration

"3-4x sales in 5 years"

revenue outlookpartially deliveredquantified

Max Life aims for 3-4 times sales growth in protection and health.

Timeframe: 5 years (by FY26)Direction: increaseConfidence: aspiration

"3-4x sales in 5 years"

Outcome check: Revenue YoY averaged 7.2% across 4 later quarter(s).

revenue outlookpartially deliveredquantified

Max Life aims for approximately 8-9 times annuity sales growth.

Timeframe: 5 years (by FY26)Direction: increaseConfidence: aspiration

"~8-9x annuity sales in 5 years"

Outcome check: Revenue YoY averaged 7.2% across 4 later quarter(s).

revenue outlooknot yet verifiablequantified

Max Life aims for approximately 8-9 times annuity sales growth.

Timeframe: 5 years (by FY26)Direction: increaseConfidence: aspiration

"~8-9x annuity sales in 5 years"

revenue outlooknot yet verifiablequantified

Max Life aims for approximately 2.5 times sales growth in offline proprietary distribution.

Timeframe: 5 years (by FY26)Direction: increaseConfidence: aspiration

"~2.5x sales in 5 years"

revenue outlookpartially deliveredquantified

Max Life aims for approximately 2.5 times sales growth in offline proprietary distribution.

Timeframe: 5 years (by FY26)Direction: increaseConfidence: aspiration

"~2.5x sales in 5 years"

Outcome check: Revenue YoY averaged 7.2% across 4 later quarter(s).

market share expansionnot yet verifiable

Max Life aims to be among the top 3 players in protection and health.

Timeframe: FY26Direction: improvementConfidence: aspiration

"Among top 3 players in protection and health"

market share expansionnot yet verifiable

Max Life aims to be among the top 3 players in protection and health.

Timeframe: FY26Direction: improvementConfidence: aspiration

"Among top 3 players in protection and health"

Technical timing lens

Trend score and candlestick chart

32Bearish

full bear SMA stack · MACD −

Stock trend: 32
Sector RS:

Technical chart

MFSLdaily · 1Y · AUTO-11.4%
Latest close ₹1548.40 on 2026-09-04
Bar
+0.7%
RSI
49
MACD hist
-2.80
52W pos
25%
2026-09-04O ₹1537.00H ₹1569.00L ₹1531.40C ₹1548.40Vol 5.4L sh
₹1.42k₹1.51k₹1.61k₹1.71k₹1.80k52L1548.402026-032026-06VolRSIMACD2026-032026-042026-062026-072026-09
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal

Daily technical trend read

Bearish setup

Trend is weak — long-term trend down. RSI 49.

  • Price < SMA20 < SMA50 < SMA200 — full bearish stack.
  • SMA20 roughly flat — short-term momentum stalled.
  • RSI(14) at 49 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 18% off 52W high · 8% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

42
RS percentile
Stage 4 Downtrend
1M return
+3.4%
3M return
-2.9%
6M return
-8.7%
1Y return
-1.0%
RS 1D
+4
RS 20D
+20
Sector rank
#9
Industry rank
#20
Stage evidence
  • Price is 4.7% below the 30-week proxy.
  • The 50-DMA is below the 30-week proxy and its slope is falling -0.7%.
  • Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
neutral
Industry
neutral
Relative-strength line vs Nifty 500 (base 100)
264 observations
04 Sept 2026Value 94.61+0.75%
8995101108114Aug 25Dec 25Apr 26Sept 2695
RS vs Nifty 50095

Valuation & score drivers

U-Score 10 · OVERVALUED · pillar breakdown, sector model, fair-value anchor

10U-SCORE
Distress Watch

Fundamental score breakdown

OVERVALUED
Valuation0/30
Growth3/25
Quality0/20
Balance Sheet0/15
Cash Flow4/10
Piotroski
5/9 (+3)
Penalties
0
Raw sum
10

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

10/100 · OVERVALUED

Positive drivers

  • Cash flow contributes 4/10 to the score.
  • Growth contributes 3/25 to the score.
  • Valuation contributes 0/30 to the score.

Main drags

  • Altman Z is 0.5, in distress territory.
  • Promoter pledge is 26.9%.
  • Fair-value margin of safety is negative at -27957.2%.
Sector valuation model

Insurance valuation: embedded value and VNB quality

Insurance economics depend on long-duration book value and new-business profitability.

Insurance P/EV
Primary lens
P/embedded value where available, plus VNB growth and margin.
Secondary checks
Persistency, product mix, solvency, distribution strength.
Main risk check
Accounting profit is less useful than embedded value quality.
PE
492.0
PB
10.1
EV/EBITDA
211.1
ROE
1.5%
ROCE
2.9%
FCF Yield
0.7%
Debt/Equity
0.3
MoS
-27957.2%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 05 Sept 2026
v4.3-runtime-valuation
Final score
10
Previous: 10
Verdict
OVERVALUED
Previous: OVERVALUED
Margin of safety
-27957.2%
Previous: -27957.2%

Score history

12 stored score snapshots. Latest stored move: +0 points.

05 Sept 2026
v4.3-runtime-valuation
10
10
10
10
10
10
10
10
10
10
10
10

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
₹104.79
-1377.6% MoS
Growth-justified P/E
1.7
Growth-justified Value
₹5.52
-27957.2% MoS
PEG

Trust score

Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth

Trust Score
55Mixed Trust · medium confidenceClaim-tested Trust

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Mixed Trust: Management has 100% delivered/partly-delivered outcomes on 3 checked claims. It ranks around the 16th percentile of the scored universe and 29th percentile within Financial Services. Main check: financial discipline is weak at 10/100.

Mixed Trust: 3/6 extracted management claims have outcome checks; 0% were fully delivered and 3 were partially delivered.

Computed 05 Sept 2026
management-trust-v1
29 extracted concalls · 3/6 claims matched
Score band
Mixed Trust

Usable, but needs evidence. Treat guidance with a margin of safety.

Relative rank
16th percentile

overall median 67 · Financial Services: 29th pctile, median 62 · Mid: 7th pctile, median 76

Evidence depth
Early sample

3/6 claims checked. Use as directional, not final.

Claim delivery
100% delivered or partly delivered

3/6 claims checked · No contradicted claim yet

How to read this Trust Score

Mixed Trust · medium confidence
What it measures
Reliability of management and financial delivery, using management claims matched with later outcomes.
Confidence
Useful directional evidence exists, but still verify the latest filings.
Investor use
Needs extra due diligence; demand valuation comfort and recent improvement.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
34
weak · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
55
watch · leverage and solvency
Discipline
10
weak · capital discipline
Results
35
weak · quarterly consistency

Trust positives

  • FCF yield is positive at 0.7%.
  • 9 years of positive FCF.
  • OPM spread across recent quarters is 1.4%.

Trust risks

  • Promoter pledge is elevated at 26.9%.
  • Altman Z is 0.47.
  • 3 latest quarters had PAT decline worse than 25% YoY.
  • Promoter holding is only 1.3%.

Financials

Full fundamentals table and 10-year revenue / profit / ROE history

Fundamentals

Valuation

P/E
492.00
P/B
10.12
EV/EBITDA
211.06
Market Cap
53438.00Cr

Profitability

ROE
1.52%
ROCE
2.87%
ROA
0.07%
Dividend Y

Growth (CAGR)

Revenue 5Y
9.00%
EPS 5Y
-28.00%
Revenue 3Y
15.00%
EPS 3Y
-40.00%

Balance Sheet

Debt/Equity
0.35
Interest Coverage
2.03×
Altman Z
0.47
Book Value
153.00

Cash Flow

FCF Yield
0.65%
FCF Positive Y
9/5
OCF
11473.00 Cr
EPS TTM
3.19

Shareholding

Promoter Hold
1.25%
Promoter Pledge
26.90%
Momentum 52W
29%

Financial History

Updated 5/9/2026

Revenue

₹ Cr
No data

Net Profit

₹ Cr
No data

Return on Equity

%
No data

Peers

Business-comparable names in Financial Services, ranked by similarity

Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.